“…Payne et al 36 Literature review C5 Picot et al 23 Case study, N ¼ 1 B2 C2, C6 Purushotham et al 35 Literature review C3 Rice et al 22 Case study, N ¼ 1 B 1 C 3 Romm et al 19 Editorial B1 C6 Shalev et al 12 Literature review A1, A2 B1 C6 D3, D4 Terpstra et al 17 Case study, N ¼ 1 B1 C1, C2, C4, C7 D1, D4 Trachsel et al 16 Theoretical article A2 Webber 20 Case study, N ¼ 1 B1, B3 C4 D4 a A denotes stigma; A1, lower quality end-of-life care; A2, misattribution of medical symptoms to a psychiatric illness; B, decisional capacity for informed consent; B1, end-of-life care decisions; B2, ability to understand a terminal illness; B3, substitute decision makers (SDMs); C, best practices; C1, psychosocial interventions; C2, pharmacology; C3, family and team collaboration; C4, goals of care; C5, setting; C6, health-care collaboration; C7, smoking; D, barriers; D1, setting; D2, communication; D3, health-care provider education; and D4, accessing care.…”